Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price

Clinical Infectious Diseases(2023)10.1093/cid/ciad566Source: DataRank Database

Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price is a research paper published in Clinical Infectious Diseases (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)Impact (FWCI 1.18)OA: hybridTopics (59)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

G. Ege Eskibozkurt ORCID,Sybil Hosek ORCID,Clare Flanagan ORCID,Raphael J. Landovitz ORCID,Elena Y Jin

Live enrichment

PubMed:37823865 PMC:PMC10874274 OpenAlex:https://openalex.org/W4387562989

National Institutes of Health

Grant: U01 HD040533

National Institutes of Health

Grant: U01 HD040474

National Institutes of Health

Grant: UM2 HD111102

National Institute on Drug Abuse

Grant: R37DA015612

National Institute on Drug Abuse

Grant: K08 HD094638

National Institute on Drug Abuse

Grant: K08 HD094638-05S1

National Institute on Drug Abuse

Grant: R01 HD079214

National Institute of Allergy and Infectious Diseases

Grant: R01 AI042006

NIDA NIH HHS

Grant: R01 DA015612

National Institutes of Health

Grant: 5R01HD079214-04

Improving outcomes for HIV-infected children in South Africa and Cote d'Ivoire

National Institutes of Health

Grant: 5R01AI042006-27

Cost-Effectiveness of Preventing HIV Complications

National Institutes of Health

Grant: 3K08HD094638-05S1

Diagnosing and preventing HIV infection in adolescents and young adults in the US: clinical impact and cost-effectiveness

National Institutes of Health

Grant: 3UM2HD111102-01S1

Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)Scientific Leadership Center; ADMIN SUPPLEMENT

National Institutes of Health

Grant: 3U01HD040474-06S1

Adol. Medicine Trials Network for HIV/AIDS Interventions

National Institutes of Health

Grant: 5R37DA015612-19

Making Better Decisions: Policy Modeling for AIDS and Drug Abuse

National Institutes of Health

Grant: 3U01HD040533-07S1

ATN Coordinating Center

Eunice Kennedy Shriver National Institute of Child Health and Human Development

FWCI

1.18

Citation Percentile

0.8%

Citation Trend

2024

2025

hybridLicense: cc-by-nc-nd

journalhttps://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciad566/52031396/ciad566.pdf

publisherhttps://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciad566/52031396/ciad566.pdf

publisherhttps://academic.oup.com/cid/article-pdf/78/2/402/56697858/ciad566.pdf

journalhttps://doi.org/10.1093/cid/ciad566

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37823865

Fields of Study

HIV/AIDS Research and InterventionsHIV/AIDS oral health manifestationsHIV-related health complications and treatments01 natural sciences03 medical and health sciences0302 clinical medicine0101 mathematicsMaleAdolescentHumansUnited StatesHomosexuality, MaleAnti-HIV AgentsPre-Exposure ProphylaxisDrugs, GenericSexual and Gender MinoritiesCost-Benefit AnalysisHIV Infections

MeSH Terms

Sexual and Gender MinoritiesAdolescentCost-Benefit AnalysisHumansMaleUnited StatesHIV InfectionsDrugs, GenericHomosexuality, MaleAnti-HIV AgentsPre-Exposure Prophylaxis

Keywords

Pre-exposure prophylaxisEmtricitabineCohortMedicineMen who have sex with menIncidence (geometry)Human immunodeficiency virus (HIV)TenofovirPublic healthCost effectivenessDemographyViral loadAntiretroviral therapyFamily medicineInternal medicineHIVYouthCost-effectivenessYmsmMaleAdolescentAnti-HIV AgentsCost-Benefit AnalysisHIV InfectionsUnited StatesSexual and Gender MinoritiesMajor ArticleHumansDrugs, GenericHomosexuality, Male

Sustainable Development Goals

SDG 0: Good health and well-being